An Open Innovation Challenge

Predicting Human Bioavailability of Subcutaneous Formulations

Log in to Add to My Schedule


Discuss a recently published paper from the SC consortium: “Predicting Bioavailability of Monoclonal Antibodies after Subcutaneous Administration: Open Innovation Challenge”. Publication highlights the challenges of predicting human bioavailability of subcutaneously administered mAbs due to a lack of reliable in vitro and preclinical in vivo predictive models and puts forth a call to action to industry and academia

Sponsored By